When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLPH - Bellerophon's nitric oxide an Orphan Drug in U.S. for IPF
Bellerophon Therapeutics Inc.
The FDA has granted Orphan Drug Designation to Bellerophon Therapeutics' (NASDAQ:BLPH) nitric oxide for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
More news on: Bellerophon Therapeutics, Inc., Healthcare stocks news, Stocks on the move,